192 related articles for article (PubMed ID: 30107970)
1. Synthesis and evaluation of 1,2,3,4-tetrahydro-1-acridone analogues as potential dual inhibitors for amyloid-beta and tau aggregation.
Lv P; Xia CL; Wang N; Liu ZQ; Huang ZS; Huang SL
Bioorg Med Chem; 2018 Sep; 26(16):4693-4705. PubMed ID: 30107970
[TBL] [Abstract][Full Text] [Related]
2. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
[TBL] [Abstract][Full Text] [Related]
3. PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.
Okuda M; Fujita Y; Hijikuro I; Wada M; Uemura T; Kobayashi Y; Waku T; Tanaka N; Nishimoto T; Izumi Y; Kume T; Akaike A; Takahashi T; Sugimoto H
J Alzheimers Dis; 2017; 59(1):313-328. PubMed ID: 28598836
[TBL] [Abstract][Full Text] [Related]
4. Identification of ortho catechol-containing isoflavone as a privileged scaffold that directly prevents the aggregation of both amyloid β plaques and tau-mediated neurofibrillary tangles and its in vivo evaluation.
Son SH; Do JM; Yoo JN; Lee HW; Kim NK; Yoo HS; Gee MS; Kim JH; Seong JH; Inn KS; Seo MD; Lee JK; Kim NJ
Bioorg Chem; 2021 Aug; 113():105022. PubMed ID: 34098397
[TBL] [Abstract][Full Text] [Related]
5. Nonphosphorylated tau slows down Aβ
Beeg M; Battocchio E; De Luigi A; Colombo L; Natale C; Cagnotto A; Corbelli A; Fiordaliso F; Diomede L; Salmona M; Gobbi M
J Biol Chem; 2021; 296():100664. PubMed ID: 33865852
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors.
Okuda M; Hijikuro I; Fujita Y; Teruya T; Kawakami H; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2016 Oct; 26(20):5024-5028. PubMed ID: 27624076
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
8. Thiophene-Based Dual Modulators of Aβ and Tau Aggregation.
Ramesh M; Acharya A; Murugan NA; Ila H; Govindaraju T
Chembiochem; 2021 Dec; 22(23):3348-3357. PubMed ID: 34546619
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review.
Malafaia D; Albuquerque HMT; Silva AMS
Eur J Med Chem; 2021 Mar; 214():113209. PubMed ID: 33548635
[TBL] [Abstract][Full Text] [Related]
10. Sunset yellow degradation product, as an efficient water-soluble inducer, accelerates 1N4R Tau amyloid oligomerization: In vitro preliminary evidence against the food colorant safety in terms of "Triggered Amyloid Aggregation".
Ojaghi S; Mohammadi S; Amani M; Ghobadi S; Bijari N; Esmaeili S; Khodarahmi R
Bioorg Chem; 2020 Oct; 103():104123. PubMed ID: 32781343
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[d][1,2]selenazol-3(2H)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant.
Wang B; Wang Z; Chen H; Lu CJ; Li X
Bioorg Med Chem; 2016 Oct; 24(19):4741-4749. PubMed ID: 27567080
[TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of Novel Hybrid 8-Hydroxy Quinoline-Indole Derivatives as Inhibitors of Aβ Self-Aggregation and Metal Chelation-Induced Aβ Aggregation.
Bowroju SK; Mainali N; Ayyadevara S; Penthala NR; Krishnamachari S; Kakraba S; Reis RJS; Crooks PA
Molecules; 2020 Aug; 25(16):. PubMed ID: 32784464
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of Trolox-conjugated amyloid-β C-terminal peptides for therapeutic intervention in an in vitro model of Alzheimer's disease.
Arai T; Ohno A; Kazunori M; Kakizawa T; Kuwata H; Ozawa T; Shibanuma M; Hara S; Ishida S; Kurihara M; Miyata N; Nakagawa H; Fukuhara K
Bioorg Med Chem; 2016 Sep; 24(18):4138-4143. PubMed ID: 27407032
[TBL] [Abstract][Full Text] [Related]
14. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
[TBL] [Abstract][Full Text] [Related]
15. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D
Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin.
Yan J; Hu J; Liu A; He L; Li X; Wei H
Bioorg Med Chem; 2017 Jun; 25(12):2946-2955. PubMed ID: 28454848
[TBL] [Abstract][Full Text] [Related]
17. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies.
Zheng Q; Kebede MT; Kemeh MM; Islam S; Lee B; Bleck SD; Wurfl LA; Lazo ND
Molecules; 2019 Jun; 24(12):. PubMed ID: 31234523
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.
Yang HL; Cai P; Liu QH; Yang XL; Li F; Wang J; Wu JJ; Wang XB; Kong LY
Eur J Med Chem; 2017 Sep; 138():715-728. PubMed ID: 28728104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
